Sleep-improving mechanism of Chaiqin Ningshen Granules in insomnia rats: based on hippocampal metabonomics.
10.19540/j.cnki.cjcmm.20211230.702
- Author:
Lin-Ru ZHAO
1
;
Pan HE
2
;
Jie LI
3
;
Ya-Jun ZHANG
3
;
Jing-Xing JIANG
3
;
Ying-Ru WU
1
;
Yue ZHANG
1
;
Jia LI
3
;
Cong LIU
3
;
Xu-Liang HAO
4
Author Information
1. Shanxi University of Chinese Medicine Jinzhong 030619, China.
2. Shanxi University Taiyuan 030006, China.
3. Shanxi Academy of Chinese Medicine Taiyuan 030012, China.
4. Affiliated Hospital of Shanxi University of Chinese Medicine Taiyuan 030024, China.
- Publication Type:Journal Article
- Keywords:
Chaiqin Ningshen Granules;
UPLC-Q-TOF-MS/MS;
insomnia;
metabonomics
- MeSH:
Animals;
Biomarkers;
Chromatography, High Pressure Liquid;
Drugs, Chinese Herbal/pharmacology*;
Estazolam;
Hippocampus/metabolism*;
Metabolomics/methods*;
Rats;
Sleep;
Sleep Initiation and Maintenance Disorders/drug therapy*
- From:
China Journal of Chinese Materia Medica
2022;47(7):1921-1931
- CountryChina
- Language:Chinese
-
Abstract:
With the ultra high performance liquid chromatography-quadruple-electrostatic field orbitrap high resolution mass spectrometry(UHPLC-Q Exactive Orbitrap-MS)-based metabonomics technology, this study aims to analyze the effect of Chaiqin Ningshen Granules(CNG) on endogenous metabolites in insomnia rats of liver depression syndrome and explore the sleep-improving mechanism of this prescription. Parachlorophenylalanine(PCPA, ip) and chronic stimulation were combined to induce insomnia of liver depression pattern in rats, and the effect of CNG on the macroscopic signs, hemorheology, and neurotransmitters in the hippocampus of insomnia rats of liver depression syndrome was observed. After the administration, rat hippocampus was collected for liquid chromatography-mass spectrometry(LC-MS) analysis of the metabolomics. Principal component analysis(PCA), partial least squares discriminant analysis(PLS-DA), and orthogonal partial least squares discriminant analysis(OPLS-DA) were employed for analyzing the metabolites in rat hippocampus and screening potential biomarkers. MetPA was used to yield the related metabolic pathways and metabolic networks. The results show that the drugs can significantly improve the mental state, liver depression, and blood stasis of rats, significantly increase the content of 5-hydroxytryptamine(5-HT) and gamma aminobutyric acid(GABA) in hippocampus(except low-dose CNG), and significantly reduce the content of glucose(Glu)(except low-dose CNG). Among them, estazolam and high-dose CNG had better effect than others. Metabolomics analysis yielded 27 potential biomarkers related to insomnia. MetPA analysis showed 4 metabolic pathways of estazolam in intervening insomnia and 3 metabolic pathways of high-dose CNG in intervening insomnia, involving purine metabolism, glycerophospholipid metabolism, histidine metabolism, and caffeine metabolism. CNG can alleviate insomnia by regulating endogenous differential metabolites and further related metabolic pathways. The result lays a basis for further elucidating the mechanism of CNG in improving sleep.
